1. Home
  2. KPTI vs SWZ Comparison

KPTI vs SWZ Comparison

Compare KPTI & SWZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

N/A

Current Price

$1.67

Market Cap

47.6M

Sector

Health Care

ML Signal

N/A

Logo Swiss Helvetia Fund Inc. (The)

SWZ

Swiss Helvetia Fund Inc. (The)

N/A

Current Price

$5.91

Market Cap

77.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
KPTI
SWZ
Founded
2008
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
47.6M
77.3M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
KPTI
SWZ
Price
$1.67
$5.91
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
1.2M
25.8K
Earning Date
05-04-2026
01-01-0001
Dividend Yield
N/A
6.59%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$146,067,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$22.36
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$1.24
$5.84
52 Week High
$10.99
$6.31

Technical Indicators

Market Signals
Indicator
KPTI
SWZ
Relative Strength Index (RSI) 24.27 39.28
Support Level N/A $5.86
Resistance Level $2.16 $6.00
Average True Range (ATR) 0.16 0.04
MACD 0.16 -0.01
Stochastic Oscillator 33.33 14.81

Price Performance

Historical Comparison
KPTI
SWZ

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

About SWZ Swiss Helvetia Fund Inc. (The)

Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. It actively manages investment solutions spanning public and private markets, wealth management, and Solutions.

Share on Social Networks: